110 related articles for article (PubMed ID: 12702151)
1. Identification of genes down-regulated during melanoma progression: a cDNA array study.
Baldi A; Battista T; De Luca A; Santini D; Rossiello L; Baldi F; Natali PG; Lombardi D; Picardo M; Felsani A; Paggi MG
Exp Dermatol; 2003 Apr; 12(2):213-8. PubMed ID: 12702151
[TBL] [Abstract][Full Text] [Related]
2. Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy.
Restifo NP; Marincola FM; Kawakami Y; Taubenberger J; Yannelli JR; Rosenberg SA
J Natl Cancer Inst; 1996 Jan; 88(2):100-8. PubMed ID: 8537970
[TBL] [Abstract][Full Text] [Related]
3. Identification of genes down-regulated during lung cancer progression: a cDNA array study.
Campioni M; Ambrogi V; Pompeo E; Citro G; Castelli M; Spugnini EP; Gatti A; Cardelli P; Lorenzon L; Baldi A; Mineo TC
J Exp Clin Cancer Res; 2008 Sep; 27(1):38. PubMed ID: 18793406
[TBL] [Abstract][Full Text] [Related]
4. The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells.
Baldi A; De Luca A; Morini M; Battista T; Felsani A; Baldi F; Catricalà C; Amantea A; Noonan DM; Albini A; Natali PG; Lombardi D; Paggi MG
Oncogene; 2002 Sep; 21(43):6684-8. PubMed ID: 12242667
[TBL] [Abstract][Full Text] [Related]
5. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.
Hoek K; Rimm DL; Williams KR; Zhao H; Ariyan S; Lin A; Kluger HM; Berger AJ; Cheng E; Trombetta ES; Wu T; Niinobe M; Yoshikawa K; Hannigan GE; Halaban R
Cancer Res; 2004 Aug; 64(15):5270-82. PubMed ID: 15289333
[TBL] [Abstract][Full Text] [Related]
6. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
[TBL] [Abstract][Full Text] [Related]
7. The coincidence of chromosome 15 aberrations and beta2-microglobulin gene mutations is causative for the total loss of human leukocyte antigen class I expression in melanoma.
Paschen A; Arens N; Sucker A; Greulich-Bode KM; Fonsatti E; Gloghini A; Striegel S; Schwinn N; Carbone A; Hildenbrand R; Cerwenka A; Maio M; Schadendorf D
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3297-305. PubMed ID: 16740750
[TBL] [Abstract][Full Text] [Related]
8. Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.
del Campo AB; Kyte JA; Carretero J; Zinchencko S; Méndez R; González-Aseguinolaza G; Ruiz-Cabello F; Aamdal S; Gaudernack G; Garrido F; Aptsiauri N
Int J Cancer; 2014 Jan; 134(1):102-13. PubMed ID: 23784959
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of pro-apoptotic genes is an early event in the progression of malignant melanoma.
Jensen EH; Lewis JM; McLoughlin JM; Alvarado MD; Daud A; Messina J; Enkemann S; Yeatman TJ; Sondak VK; Riker AI
Ann Surg Oncol; 2007 Apr; 14(4):1416-23. PubMed ID: 17195911
[TBL] [Abstract][Full Text] [Related]
10. cDNA-array profiling of melanomas and paired melanocyte cultures.
Mischiati C; Natali PG; Sereni A; Sibilio L; Giorda E; Cappellacci S; Nicotra MR; Mariani G; Di Filippo F; Catricalà C; Gambari R; Grammatico P; Giacomini P
J Cell Physiol; 2006 Jun; 207(3):697-705. PubMed ID: 16523488
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers.
Bertucci F; Pages C; Finetti P; Rochaix P; Lamant L; Devilard E; Nguyen C; Houlgatte R; Birnbaum D; Xerri L; Brousset P
Anticancer Res; 2007; 27(5A):3441-9. PubMed ID: 17970093
[TBL] [Abstract][Full Text] [Related]
12. Distinct MHC gene expression patterns during progression of melanoma.
Degenhardt Y; Huang J; Greshock J; Horiates G; Nathanson K; Yang X; Herlyn M; Weber B
Genes Chromosomes Cancer; 2010 Feb; 49(2):144-54. PubMed ID: 19862823
[TBL] [Abstract][Full Text] [Related]
13. Defective human leukocyte antigen class I-associated antigen presentation caused by a novel beta2-microglobulin loss-of-function in melanoma cells.
Chang CC; Ogino T; Mullins DW; Oliver JL; Yamshchikov GV; Bandoh N; Slingluff CL; Ferrone S
J Biol Chem; 2006 Jul; 281(27):18763-73. PubMed ID: 16648140
[TBL] [Abstract][Full Text] [Related]
14. Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues.
Jaeger J; Koczan D; Thiesen HJ; Ibrahim SM; Gross G; Spang R; Kunz M
Clin Cancer Res; 2007 Feb; 13(3):806-15. PubMed ID: 17289871
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of thrombospondin 2 in primary and metastatic malignant melanoma.
Kunz M; Koczan D; Ibrahim SM; Gillitzer R; Gross G; Thiesen HJ
Acta Derm Venereol; 2002; 82(3):163-9. PubMed ID: 12353704
[TBL] [Abstract][Full Text] [Related]
16. Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis.
Hao X; Sun B; Hu L; Lähdesmäki H; Dunmire V; Feng Y; Zhang SW; Wang H; Wu C; Wang H; Fuller GN; Symmans WF; Shmulevich I; Zhang W
Cancer; 2004 Mar; 100(6):1110-22. PubMed ID: 15022276
[TBL] [Abstract][Full Text] [Related]
17. Identification of metastasis-associated genes by transcriptional profiling of a metastasizing versus a non-metastasizing human melanoma cell line.
Brem R; Hildebrandt T; Jarsch M; Van Muijen GN; Weidle UH
Anticancer Res; 2001; 21(3B):1731-40. PubMed ID: 11497253
[TBL] [Abstract][Full Text] [Related]
18. Rapid identification of dysregulated genes in cutaneous malignant melanoma metastases using cDNA technology.
Mirmohammadsadegh A; Baer A; Nambiar S; Bardenheuer W; Hengge UR
Cells Tissues Organs; 2004; 177(3):119-23. PubMed ID: 15388985
[TBL] [Abstract][Full Text] [Related]
19. Low-dose IFN-gamma induces tumor MHC expression in metastatic malignant melanoma.
Propper DJ; Chao D; Braybrooke JP; Bahl P; Thavasu P; Balkwill F; Turley H; Dobbs N; Gatter K; Talbot DC; Harris AL; Ganesan TS
Clin Cancer Res; 2003 Jan; 9(1):84-92. PubMed ID: 12538455
[TBL] [Abstract][Full Text] [Related]
20. Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenografts.
Xi Y; Riker A; Shevde-Samant L; Samant R; Morris C; Gavin E; Fodstad O; Ju J
Cancer Genomics Proteomics; 2008; 5(1):1-35. PubMed ID: 18359977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
